nemolizumab

News mentioning nemolizumab · Wikidata · RSS

Top stories

Latest

1. EADV 2026: Galderma's New Data Show Sustained Improvements with Nemluvio (nemolizumab) for up to Three Years in Patients With Moderate-to-severe Atopic Dermatitisfinanznachrichten.de · 2026-09-30 05:22 UTC · story
2. EADV 2026: Galderma's New Data Show Sustained Improvements with Nemluvio® (nemolizumab) for up to Three Years in Patients With Moderate-to-severe Atopic Dermatitisthewhig.com · 2026-09-30 05:04 UTC · story